ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab.
about
Principles of separation: indications and therapeutic targets for plasma exchange.Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.The role of therapeutic apheresis in high immunologic risk renal transplantation: a review of current trends.Therapeutic apheresis in kidney transplantation: a review of renal transplant immunobiology and current interventions with apheresis medicine.Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action.Use of monoclonal antibodies in renal transplantation.Baseline Anti-blood Group Antibody Titers and their Response to Desensitization and Kidney Transplantation.Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.A case of nearly mistaken AB para-Bombay blood group donor transplanted to a group 'O' recipient.Behaviour of non-donor specific antibodies during rapid re-synthesis of donor specific HLA antibodies after antibody incompatible renal transplantation.Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients.ABO Incompatible Kidney Transplantation-Current Status and Uncertainties.Synthetic blood group antigens for anti-A removal device and their interaction with monoclonal anti-A IgM.Current progress in ABO-incompatible kidney transplantationRational clinical trial design for antibody mediated renal allograft injury.Characteristics of protein-carbohydrate interactions as a basis for developing novel carbohydrate-based antirejection therapies.Therapeutic apheresis--state of the art in the year 2005.Transplantation across previously incompatible immunological barriers.Excellent long term patient and renal allograft survival after ABO-incompatible kidney transplantation: Experience of one center.B cells: a rational target in alloantibody-mediated solid organ transplantation rejection.The emerging role of rituximab in organ transplantation.ABO-incompatible renal transplantation in developing world - crossing the immunological (and mental) barrier.New treatments for acute humoral rejection of kidney allografts.Successful renal transplantation with desensitization in highly sensitized patients: a single center experience.Living donor transplant options in end-stage renal disease patients with ABO incompatibilityTreatment of large plasma volumes using specific immunoadsorption to desensitize ABO-incompatible kidney-transplant candidates.Production of human blood group B antigen epitope conjugated protein in Escherichia coli and utilization of the adsorption blood group B antibody.Transfusion medicine and solid organ transplant - Update and review of some current issues.ABO blood group incompatibility: a diminishing barrier to successful kidney transplantation?Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach.Immunohaematological and apheretic aspects of the first kidney transplant from a living, ABO-incompatible donor carried out in Italy.Current approaches to the management of highly sensitized kidney transplant patients.Update on the role of rituximab in kidney diseases and transplant.Beyond dialysis: current and emerging blood purification techniques.Prevention of antibody-mediated kidney transplant rejection.Immunosuppressive drug therapy.Molecular deciphering of the ABO system as a basis for novel diagnostics and therapeutics in ABO incompatible transplantation.B cell depletion: rituximab in glomerular disease and transplantationKidney paired donation: principles, protocols and programs.An update on ABO-incompatible kidney transplantation.
P2860
Q26830899-53FF2B42-0A09-4EBB-9261-0A4801F48D89Q30276550-A1ADF015-6CE2-4337-8605-67252A314F42Q30455087-304C1F68-610C-4F8F-9DCC-AF2915E2FF18Q30456482-0DA9916B-638A-46C3-9526-87919933C3A1Q33370836-1BA81C47-6167-46F7-AF44-00691932DC4CQ33396236-8BA17EE1-9A41-456B-AD5C-832F3A07AC03Q33697381-EC728EB9-214F-4CC5-A692-C0918013DF58Q34122035-29D50D8F-33D7-4044-993D-52FCE0F80881Q34439147-6207CE1E-110D-4496-8575-1876C591FD88Q34901704-D1E32CE8-E761-4F6F-AB91-56B4A4901573Q35543289-7133D9EE-A02D-4E2B-A76D-C5C7FDA3DDDAQ35607565-553A0F4E-6D19-4612-B95A-2358CB1979BAQ35925181-F1CF792E-51E7-478C-8DB8-75ACF729E03EQ36171175-2DF82543-B680-4F00-B208-0A830502A779Q36173541-796A4F1E-C14F-4B50-89DC-ED909C9140AAQ36304925-7D2B4811-575B-4DF9-B8A5-1157546CA1DBQ36341821-9A03344B-81FC-45A0-9D28-C32936145C03Q36379447-C00C73F9-D8FA-4C59-AE4D-D7C999D6031CQ36400872-CCCEFC3A-AF22-45F2-A618-603BE4D7C5CDQ36429791-71108703-E457-405C-A669-4512D43D5C6BQ36530278-A20C379D-8B5B-4522-856A-459619AFD2ABQ36696495-0AC157B8-FD30-4CAC-82A7-18AB302DE793Q36802609-1F39922E-90CC-4EEE-BADD-6979D85F5974Q37078119-B1DD0C98-9DCE-409D-AAC0-798DA969FFE6Q37080689-171D5EC7-8E6F-4C12-9905-E9C796F0E1A3Q37127991-77F975A3-1B03-4FD0-B1AC-B7F521C02B27Q37170056-0EA18AD8-E634-4369-A4B3-F6AFD8650984Q37390956-181FFBC2-9688-42A7-94A2-A36DC0DF6E4AQ37803412-0E62F03E-4E0D-4A90-9CF9-AA6404CC2FBFQ37820338-85CB8E3D-E304-487A-A99A-2663D5CDF928Q37830813-FD523538-8C71-4691-9514-54DF6AD3B079Q37836967-9EB21677-9E58-44A7-843E-48691D8A63A3Q37970443-123E1B43-5970-44D9-B216-E855AB07E8DFQ37994745-D3579F9C-0CBF-4855-913E-D2724C3E646CQ38010231-437644E0-4580-444E-B298-CCE41DC9CEEEQ38134066-699201C0-DDF6-44CB-91A7-D8CA5507A12CQ38172280-A9731D37-D672-45AA-8731-A360AA50CABEQ38189360-BBFB4001-3868-4571-8F9E-F102AFBC5A32Q38258064-A7FDA80D-06E2-4930-9C03-4E295B19CB87Q38267202-F67E22B7-E582-41C0-A642-6885FC4AAA1C
P2860
ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
ABO incompatible kidney transp ...... mmunoadsorption and rituximab.
@ast
ABO incompatible kidney transp ...... mmunoadsorption and rituximab.
@en
ABO incompatible kidney transp ...... mmunoadsorption and rituximab.
@nl
type
label
ABO incompatible kidney transp ...... mmunoadsorption and rituximab.
@ast
ABO incompatible kidney transp ...... mmunoadsorption and rituximab.
@en
ABO incompatible kidney transp ...... mmunoadsorption and rituximab.
@nl
prefLabel
ABO incompatible kidney transp ...... mmunoadsorption and rituximab.
@ast
ABO incompatible kidney transp ...... mmunoadsorption and rituximab.
@en
ABO incompatible kidney transp ...... mmunoadsorption and rituximab.
@nl
P2093
P2860
P1476
ABO incompatible kidney transp ...... immunoadsorption and rituximab
@en
P2093
Gunilla Kumlien
Gunnar Tydén
Ingela Fehrman
John Sandberg
Torbjörn Lundgren
P2860
P304
P356
10.1111/J.1600-6143.2004.00653.X
P407
P577
2005-01-01T00:00:00Z